| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |